Variations in hemoglobin levels among PLWH undergoing antiretroviral therapy
Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya 60132, Indonesia.
Review Article
World Journal of Advanced Research and Reviews, 2024, 24(03), 3185-3190
Publication history:
Received on 16 November 2024; revised on 28 December 2024; accepted on 30 December 2024
Abstract:
Haemoglobin levels are critical biomarkers that reflect oxygen transport and metabolic health, particularly in individuals living with HIV/AIDS (PLWH) undergoing antiretroviral therapy (ARV). This scoping review explores the interplay between hemoglobin variations, ARV regimens, and health outcomes in PLWH populations. Studies demonstrate that hemoglobin levels directly influence treatment efficacy and overall well-being. Evidence highlights that ARV regimens such as zidovudine are strongly associated with alterations in hemoglobin levels due to their hematological effects. Nutritional interventions, including iron and folate supplementation, have shown promise in supporting hemoglobin production and mitigating adverse outcomes. The findings underline the need for comprehensive strategies combining ARV regimen adjustments, nutritional therapy, and regular monitoring to improve quality of life and treatment adherence among PLWH patients.
Keywords:
Hemoglobin; HIV/AIDS; Antiretroviral therapy; PLWH
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0